Carestream Health India announces the launch of The DRX Compass, an accurate, convenient & configurable digital radiology solution designed to provide radiologists with a whole new level of efficiency. Additionally, DRX Compass offers the versatility to build the desired configuration from a wide range of
- Becomes world’s first company to bring genomics based infectious diseases diagnostic to hospitals - Universal ID test, a revolutionary single test solution for accurate and timely diagnosis of infectious diseases - Tests to be rolled out over the next three months in partnership with
The Investment will help bolster the out-of-hospital care segment in the country - a critical need in view of shortage of hospitals to deliver the best possible health outcomes and quality of life for patients while increasing the access and affordability Health-tech company HCAH (HealthCare atHOME)
Redcliffe Labs, also known as Redcliffe Life Diagnostics (https://redcliffelabs.com/), a unit of Redcliffe Lifetech in the U.S. and India, recently launched a large Regional Reference lab in Bangalore atREDCLIFFE LIFETECH PRIVATE LIMITED, Building No 168, 1st Floor, Sarathy, 9th Main, Sector 6, HSR Layout, Bangalore:
Amit Gandhi, Business Leader MRI, CT & AMI, Philips Indian Subcontinent The increased demand for medical imaging over the last few years, especially because of the pandemic, has resulted in radiology workflows becoming more complex. These developments have necessitated development of new and innovative ways of working
Mr. Rajesh Patel, CEO - IVD, India Trivitron Healthcare In India, we often hear this famous adage, 'Prevention is better than cure.' As our population increases, health-related issues become more common, which calls for the advancement of technology to detect and treat such issues. Discovering and treating health
Remote care emerges as a top priority for Indian business leaders Indian healthcare leaders looking to invest in telehealth and AI to drive digital transformation Difficulties with data management and lack of interoperability emerge as challenges for adoption of digital technologies Royal Philips (NYSE: PHG, AEX: PHIA),
Strengthens offerings & continues to be at the forefront of COVID care Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems